Changes

Jump to: navigation, search

Avatrombopag (Doptelet)

879 bytes added, 08:40, 7 July 2014
Created page with "==Mechanism of action== Thrombopoietin receptor agonist ==Preliminary data== <span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; ..."
==Mechanism of action==
Thrombopoietin receptor agonist

==Preliminary data==
<span
style="background:#00CD00;
padding:3px 6px 3px 6px;
border-color:black;
border-width:2px;
border-style:solid;">Randomized Phase II, >20 per arm</span>
# Bussel JB, Kuter DJ, Aledort LM, Kessler CM, Cuker A, Pendergrass KB, Tang S, McIntosh J. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia. Blood. 2014 Jun 19;123(25):3887-94. Epub 2014 May 6. [http://bloodjournal.hematologylibrary.org/content/123/25/3887.long link to original article] [http://www.ncbi.nlm.nih.gov/pubmed/24802775 PubMed]

==Also known as==
YM477, AKR 501

[[Category:Investigational]]

[[Category:Hematopoietic growth factors]]
[[Category:Megakaryocyte growth factors]]

[[Category:Immune thrombocytopenic purpura (ITP) medications]]
LookupUsers, editors, emailconfirmed
23,627
edits

Navigation menu